Dr Reddy’s Laboratories Ltd and Takeda Pharmaceutical Company Limited, through its Indian subsidiary Takeda Biopharmaceuticals
Dr Reddy’s Laboratories has received approval from the US Food and Drug Administration (USFDA) for
Dr Reddy’s Laboratories has announced the launch of Bosutinib Tablets 400 mg in the United
Dr Reddy’s Laboratories Ltd, a global pharmaceutical company, has secured a Notice of Compliance (NOC)
Dr Reddy’s Laboratories has announced the launch of Obeda®, India’s first generic injectable semaglutide approved
Dr Reddy’s Laboratories Ltd (BSE: 500124, NSE: DRREDDY, NYSE: RDY, NSEIFSC: DRREDDY), together with its
Dr  Reddy’s Laboratories Ltd has received marketing authorization from the European Commission for AVT03, its
Dr Reddy’s Laboratories Ltd, a prominent pharmaceutical company based in Hyderabad, announced on Friday that
Dr. Reddy’s Laboratories has announced the inauguration of a state-of-the-art biologics facility in Hyderabad, dedicated
Prominent Indian drug makers Dr Reddy’s Laboratories, Sun Pharma, and Aurobindo Pharma have initiated recalls
